Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Orthovita, an orthobiologics and biosurgery company, has appointed William Tidmore as its new chairman of the board, following the resignation of David Fitzgerald as chairman of the board and a director of the company.
Subscribe to our email newsletter
Mr Tidmore has served as a member of Orthovita’s board of directors since 2007 and has over 20 years of experience in the spine and orthopedic industry.
Mr Tidmore was formerly president and chairman of DePuy Acromed, as well as president of DePuy, which was acquired by Johnson & Johnson in 1999.
Antony Koblish, president and CEO of Orthovita, said: “Under his guidance, Orthovita significantly increased sales, completed several key equity and debt financings, acquired marketing rights for two hemostasis products and made substantial progress in product development.
“We look forward to solid leadership from Bill Tidmore and the contributions that his extensive experience in the orthopedic and spine industry will bring.”